Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
ALDH1A1-IN-2
Cat. No.:
OB0425LY-092
Appearance:
Solid
Purity:
99.31%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
ALDH1A1-IN-2 is a high-purity aldehyde dehydrogenase 1a1 (aldh1a1) inhibitor.
Synonyms:
2231081-18-6; 1-[4-[6-Chloro-3-(4-methylsulfonylpiperazine-1-carbonyl)quinolin-4-yl]phenyl]cyclopropane-1-carbonitrile
CAS No.:
2231081-18-6
Compound CID:
142581197
Formula:
C25H23ClN4O3S
Formula Weight:
494.99
Specification
Target:
Aldehyde dehydrogenase (ALDH)
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
ALDH1A1-IN-2 can be used to study cancer, inflammation or obesity.
